Eseng Lai

2.6k citations

60 papers · 1.8k indexed · h-index 20

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management 12
- Diabetes Management and Research 4
- Hormonal and reproductive studies 4
Genetics top 5%
Neurology top 5%
Developmental Neuroscience top 10%
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 7
- Pharmacology and Obesity Treatment 5
Molecular Biology
- Metabolism, Diabetes, and Cancer 6
Cardiology and Cardiovascular Medicine
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Heart Failure Treatment and Management 5

Co-authors: Gary P. O’Neill Keith D. Kaufman Stacy A. Rudnicki Marek Gawel Barry W. Festoff Mike Murphy F. H. Norris Deborah Gelinas
Cited by: Endocrinology, Diabetes and Metabolism Genetics Neurology
Journals: The Journal of Clinical Pharmacology (8 papers)American Journal of Therapeutics (6 papers)Neurology (3 papers)
Partner nations: United States Belgium Canada

In The Last Decade

Eseng Lai

59 papers receiving 1.7k citations

Peers

Countries citing papers authored by Eseng Lai

Since Specialization

Citations

This map shows the geographic impact of Eseng Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eseng Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eseng Lai more than expected).

Fields of papers citing papers by Eseng Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eseng Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eseng Lai. The network helps show where Eseng Lai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eseng Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eseng Lai Line = papers co-authored together Eseng Lai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults Vaccine ·Jesse C. Nussbaum,Domingo Eugenio,Radha Railkar,Jeffrey R. Sachs,Daniel S. Spellman,Juin-Kae Lee,Christine A. Shaw,Pedro J. Cejas,Michael Citron,Mohamed Al‐Ibrahim,David Han,Muslima Bashbayeva,S. Aubrey Stoch,Eseng Lai,Andrew J. Bett,Amy S. Espeseth	2023	12
2	Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial EBioMedicine ·Frédéric Vanhoutte,Wen Liu,Richard T. Wiedmann,Rita Tömösköziné dr. Farkas,Domingo Eugenio,Andrea Cabot Echevarría,Antonios O. Aliprantis,Preeti Sharma,Jonathan Hartzel,Jianing Li,B. A. Blakesley,Katrin Ramsauer,唯人山本,Roland Tschismarov,Deborah D. Brown,Weifeng Xu,Jeffrey R. Sachs,Kevin L. Russell,S. Aubrey Stoch,Eseng Lai	2022	18
3	A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults Human Vaccines & Immunotherapeutics ·Antonios O. Aliprantis,Christine A. Shaw,Paul Griffin,Nicholas Farinola,Radha Railkar,Domingo Eugenio,Wen Liu,Jeffrey R. Sachs,Martin Watt Coull,Heather Lee,Kara S. Cox,Daniel S. Spellman,Colleen J. Winstead,Igor Smolenov,Eseng Lai,Tal Zaks,Amy S. Espeseth,Lori Panther	2020	111
4	A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control Diabetes Therapy ·(unknown),Ira Gantz,Taro Okamoto,Yuka Ito,Asako Sato,Kotoba Okuyama,Edward A. O’Neill,Samuel S. Engel,Eseng Lai	2017	5
5	Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans Xenobiotica ·Christopher R. Gibson,Ping Lü,Andreas Rengga,Anagha Aravind,Zoe Barter,K Rowland‐Yeo,Mark Stroh,Eseng Lai,Deborah A. Nicoll‐Griffith	2013	15
6	The effects of laropiprant, a selective prostaglandin D₂receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin Platelets ·Aimée Dallob,Wen‐Lin Luo,Peter D. Young,G. Dickten,Amy O. Johnson‐Levonas,Jules I. Schwartz,Victor Dishy,Walter K. Kraft,Jan de Hoon,Anne Van Hecken,Inge De Lepeleire,Waldemar Radziszewski,John A. Wagner,Eseng Lai	2011	8
7	Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients The Journal of Clinical Pharmacology ·Marc L. Reitman,Victor Dishy,Rok Vukmanič,William S. Denney,Chengcheng Liu,Walter K. Kraft,Whisloney do Espírito Santo Souza Júnior,Mark Matson,S. Aubrey Stoch,John A. Wagner,Eseng Lai	2011	38
8	A Single Supratherapeutic Dose of Rolofylline Does Not Prolong the QTcF Interval in Healthy Volunteers American Journal of Therapeutics ·Waldemar Radziszewski,Eseng Lai,dilek katrancı,Mark Stroh,Victor Dishy,Lingling Han,William Lewis,Amy O. Johnson‐Levonas,泰英山崎,John A. Wagner	2010	1
9	The Effects of Multiple Doses of Rolofylline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Subjects American Journal of Therapeutics ·Mark Stroh,Victor Dishy,Waldemar Radziszewski,Eunhee Hwang,Livia Menezes,Howard C. Dittrich,Amy O. Johnson‐Levonas,泰英山崎,John A. Wagner,Eseng Lai	2010	3
10	Effects of Laropiprant, a Selective Prostaglandin D₂ Receptor 1 Antagonist, on the Pharmacokinetics of Rosiglitazone Cardiovascular Therapeutics ·Jules I. Schwartz,Mark Stroh,Bing Gao,Fang Liu,Sarah Margrave,Stefan Zajic,Alan J. Meehan,Jon Ruckle,Eseng Lai,John A. Wagner	2009	4
11	Effect of Laropiprant, a PGD2 Receptor 1 Antagonist, on Estradiol and Norgestimate Pharmacokinetics After Oral Contraceptive Administration in Women American Journal of Therapeutics ·Jules I. Schwartz,Fang Liu,Yinghong Wang,Barnali Pramanik,Amy O. Johnson‐Levonas,María J. Gutiérrez,Eseng Lai,John A. Wagner	2009	2
12	Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis Journal of Allergy and Clinical Immunology ·George Philip,Janet van Adelsberg,Tom Loeys,Nancy Liu,严永斌,Eseng Lai,Sairia Dass,Theodore F. Reiss	2009	47
13	Influence of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, on the Pharmacokinetics and Pharmacodynamics of Warfarin American Journal of Therapeutics ·Jules I. Schwartz,Fang Liu,Mark Stroh,久美大里,Amy O. Johnson‐Levonas,Kenneth C. Lasseter,Eseng Lai,John A. Wagner	2009	4
14	Effects of Aspirin When Added to the Prostaglandin D₂ Receptor Antagonist Laropiprant on Niacin‐Induced Flushing Symptoms The Journal of Clinical Pharmacology ·Victor Dishy,Fang Liu,David L. Ebel,George Atiee,Jane Royalty,Florian Urs Bernlochner,John F. Paolini,John A. Wagner,Eseng Lai	2009	16
15	Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial International Journal of Clinical Practice ·John F. Paolini,Yale Mitchel,Rafael Reyes,Maria Henriquez-Berrocal,Qinfen Yu,Eseng Lai,Jon Silver,Josephine M. Norquist,Christine McCrary Sisk,Harold Bays	2008	14
16	The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers European Journal of Clinical Pharmacology ·A. Van Hecken,Nim Ismaniah,Inge De Lepeleire,Chau Thach,Kamaruzzaman B.Y.,Ryo Yanagisawa,Tine Laethem,Kathryn Mazina,Tami Crumley,Larissa Wenning,Yutaka Kikuchi,Paul Deutsch,Péter Clement,Eseng Lai,Jan de Hoon	2007	29
17	Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix. The American Journal of Cardiology ·John F. Paolini,Yale Mitchel,Robert Reyes,Uma Kher,Eseng Lai,Douglas J. Watson,Josephine M. Norquist,Alan G. Meehan,Harold Bays,Michael Davidson,Christie M. Ballantyne	2007	128
18	Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist Clinical Pharmacology & Therapeutics ·Eseng Lai,Kübra Sevim,Michael Borrasch,Inge De Lepeleire,Fang Liu,Enith Martin Williams,Anne Van Hecken,Nim Ismaniah,D Hilliard,Howard Greenberg,Gary P. O’Neill,Kathleen M. Metters,Yutaka Kikuchi,JA Wagner	2007	41
19	Absorption, Metabolism, and Excretion of [14C]MK-0524, a Prostaglandin D2 Receptor Antagonist, in Humans Drug Metabolism and Disposition ·Bindhu V. Karanam,Maria Madeira,Scott A. Bradley,Larissa Wenning,N. A. Cafarova,普列沙科夫,Takayuki Okino,E.N. Shulga,Brian Dean,George A. Doss,Micaël Aguedjou,Tami Crumley,Ajay Nirula,Eseng Lai	2007	24
20	Telencephalic progenitors maintain anteroposterior identities cell autonomously Current Biology ·Erqian Na,Maria McCarthy,Christine Neyt,Eseng Lai,Gord Fishell	1998	34

About Eseng Lai

Eseng Lai is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Cardiology and Cardiovascular Medicine, Internal Medicine and Geriatrics and Gerontology, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Pharmacogenetics and Drug Metabolism (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Pharmacology and Obesity Treatment (5 papers), Heart Failure Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Hormonal and reproductive studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (620 citations), Genetics (189 citations), Neurology (268 citations), Developmental Neuroscience (69 citations) and Pharmacology (260 citations). Eseng Lai has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Gary P. O’Neill, Keith D. Kaufman, Stacy A. Rudnicki, Marek Gawel, Barry W. Festoff, Mike Murphy, F. H. Norris, Deborah Gelinas, Howard M. Natter and R Kratz. Their work appears in journals such as The Journal of Clinical Pharmacology, American Journal of Therapeutics, Neurology, Current Medical Research and Opinion and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact